Latest news for HUMBL (OTC:HMBL) Stock

HUMBL Inc is a digital commerce company. It operates a platform to connect consumers, businesses, and governments in the digital economy. HUMBL provides simple tools and packaging for complex new technologies such as blockchain, in the same way that previous cycles of e-commerce and the cloud were more simply packaged by companies such as Facebook, Apple, Amazon and Netflix over the past several decades. The company's segment includes Consumer and Commercial. It generates maximum revenue from the Consumer segment. They account for revenues based on the verticals in which they were earned, the three principal verticals being HUMBL Wallet, and HUMBL Marketplace, HBS.

cannabis shacking hands (lindsayfox and Tusumi by Pixabay)(7)

Cannabis

News

Movers & Shakers

AFCG

CSE:HMBL

CSE:IAN

CSE:MMEN

CSE:MRMD

CWBHF

CWEB

FLGC

HMBL

HUMBF

ITHUF

KAVL

MMNFF

MRMD

PCLOF

TSXV:PCLO

UNRIVALED BRANDS INC by Unrivaled Brands, Inc.

UNRV

Top Cannabis Industry Leaders Who Took The Reins In 2023

HUMBL Inc

Hims &amp; Hers Health Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIMS#NYSE">HIMS</a>) shares are trading lower Thursday in possible sympathy with Eli Lilly And Co&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>), after the U.S. Food and Drug Administration removed it from the weight-loss and diabetes drugs <a href="https://www.benzinga.com/markets/equities/24/09/40672154/eli-lilly-launches-discounted-mounjaro-and-zepbound-as-fight-against-compounded-imitations-escal">shortage list</a>.
What Happened: The FDA said in a <a href="https://www.fda.gov/drugs/drug-safety-and-availability/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize">statement</a> late Wednesday that Eli Lilly's supply of Mounjaro, which is used to treat diabetes, and weight-loss drug Zepbound can now keep up with current demand. 
Mounjaro had been on the regulator&#8217;s shortage list since late 2022, and Zepbound had been on the list since April.
&#8220;FDA confirmed with the drug's manufacturer that their stated product availability and manufacturing capacity can meet the present and projected national demand. Patients and prescribers may still see intermittent localized supply disruptions as the products move through the supply chain from the manufacturer and distributors to local pharmacies,&#8221; the FDA said.
Hims &amp; Hers Health shares are under pressure on Thursday as the firm sells cheaper versions of the aforementioned drugs, known as compounded drugs. Hims &amp; Hers said in May that it would&nbsp;begin selling compounded versions&nbsp;of GLP-1 injections. Shares surged on the news and have more than doubled since the start of the year.
Don&#8217;t Miss: <a href="https://www.benzinga.com/general/biotech/24/07/39656549/exclusive-glp-1-weight-loss-drugs-could-become-a-trillion-dollar-market-predicts-tema-etfs-ceo">EXCLUSIVE: GLP-1 Weight-Loss Drugs Could Become A Trillion-Dollar Market, Predicts Tema ETFs CEO</a>
The limited supply for weight-loss and diabetes drugs from Lilly and rival Novo Nordisk A/S (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) sparked a demand boom for compounded drugs, which are made by combining, mixing, or altering drug ingredients, per Reuters.
The report also indicates that regulators allow compounded versions of drugs to enter the market to meet demand when there is a shortage. When there is no shortage, compounded drug makers are reportedly unable to make &#8220;regular or inordinate amounts&#8221; of the drugs.
Lilly reportedly began selling vials of its lowest dose of Zepbound in the U.S. directly to consumers via its website to help push back against the rise of compounded versions of the drug. Novo Nordisk&#8217;s drugs were still listed on the FDA&#8217;s shortage list as of Thursday. 
HIMS Price Action: <a href="http://benzinga.com/quote/hims">Hims &amp; Hers Health shares</a> were down 8.92% at $17.26 at the time of publication, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Photo: Natalia Varlei from Shutterstock.

Movers

Hims & Hers Health, Inc. Class A Common Stock

HIMS

Hims & Hers Health Stock Is Tumbling Thursday: Here's Why

HNI Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HNI#NYSE">HNI</a>) announced today Marshall H. Bridges notified the Corporation on September 27, 2024, of his decision to retire as Senior Vice President and Chief Financial Officer (CFO), effective December 28, 2024.
On October 1, 2024, the Board of Directors appointed Vincent Paul (VP) Berger II as Executive Vice President (EVP) and CFO, effective December 29, 2024. Mr. Berger, age 52, is a 27-year HNI member, serving as EVP and President of Hearth and Home Technologies since 2016. Mr. Berger is a certified public accountant and an experienced business executive with more than 30 years of experience in various finance, operational, and leadership roles.
Following his retirement from full-time employment, Mr. Bridges will continue in a part-time role assisting the Corporation with strategic projects focused in the area of artificial intelligence.

Management

HNI Corporation Appoints Vincent Paul Berger II As Executive Vice President And CFO, Effective December 29, 2024; Marshall H. Bridges Notified The Corporation Of His Decision To Retire As Senior Vice President And CFO, Effective December 28, 2024

WIIM

TOVX

Theriva Biologics shares are trading higher after the company announced the Data and Safety Monitoring Committee's review outcome for its Phase 1b/2a clinical trial of SYN-004. The DSMC has recommended the study proceed to enroll cohort 3.

Diana Shipping Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DSX#NYSE">DSX</a>), (the "Company"), a global shipping company specializing in the ownership and bareboat charter-in of dry bulk vessels, today announced that, through a separate wholly-owned subsidiary, it has extended the time charter contract with Aquavita International S.A., for one of its Post-Panamax dry bulk vessels, the m/v Phaidra. The gross charter rate is US$12,000 per day, minus a 4.75% commission paid to third parties, for a period until minimum May 1, 2025 up to maximum July 15, 2025. The new charter period is expected to commence on October 11, 2024. &nbsp;
The "Phaidra" is a 87,146 dwt Post-Panamax dry bulk vessel built in 2013.
The employment of "Phaidra" is anticipated to generate approximately US$2.4 million of gross revenue for the minimum scheduled period of the time charter.

Contracts

Diana Shipping Announces Direct Continuation Of Time Charter Contract For m/v Phaidra With Aquavita; The Employment Of "Phaidra" Is Anticipated To Generate ~$2.4M Of Gross Revenue For The Minimum Scheduled Period Of The Time Charter

WOLF

Wolfspeed shares are trading lower after Mizuho downgraded the stock from Neutral to Underperform and cut its price target from $17 to $8.

Mizuho analyst David Bellinger reiterates Five Below (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIVE#NASDAQ">FIVE</a>) with a Neutral and maintains $85 price target.

Price Target

Reiteration

Analyst Ratings

FIVE

Mizuho Reiterates Neutral on Five Below, Maintains $85 Price Target

EVGO

EVgo shares are trading higher after the company announced it received a $1.05 billion conditional commitment for a Department of Energy (DOE) loan guarantee to accelerate the buildout of public fast charging across the US.

California&#8217;s recent decision to implement emergency rules severely limiting hemp products has sparked concerns throughout <a href="https://www.benzinga.com/cannabis">the cannabis industry. </a>
Governor Gavin Newsom&#8216;s action is part of a broader regulatory trend that could shape the future of cannabis markets nationwide. As the cannabis industry continues to evolve, the question remains: how will these restrictions impact both state-licensed operators and consumers?
Matt Hawkins, founder and managing partner of Entourage Effect Capital, shared his perspective on how these restrictions could affect the market during an interview ahead of his appearance at the <a href="https://www.benzinga.com/events/cannabis-conference/">Benzinga Cannabis Capital Conference</a>.
<h3 class="wp-block-heading">Impact on the Legal Market</h3>
"California wasn't the first state to ban intoxicating hemp-derived products, and it likely won't be the last," Hawkins said. These regulations are creating ripple effects across the cannabis and hemp industries, with businesses and consumers closely watching the outcomes.
While California's actions are significant, Hawkins believes federal regulations could change the landscape even further. "A new farm bill could, of course, ban these products federally. States would react to a federal ban whichever way they deem appropriate, regardless of California's stance," he said. 
This creates a complex environment where state laws could either align with or diverge from federal mandates, affecting businesses differently depending on location.
<h3 class="wp-block-heading">Legal Market vs. Illicit Market</h3>
The introduction of such bans presents challenges for both businesses and consumers. "These bans push consumers who want to stay in the legal market back to the state-licensed operators. An absence of bans does the opposite," he said.
This dynamic means certain businesses could benefit from a shift toward state-regulated markets, while others might struggle under tighter regulations. Hawkins emphasized that no matter how the laws evolve, some companies will inevitably face losses.
<h3 class="wp-block-heading">A Changing Regulatory Environment</h3>
With ongoing regulatory shifts, the cannabis industry is facing continued uncertainty. Whether through state-level restrictions or potential federal changes, the market will need to adapt to new frameworks governing both cannabis and hemp products. As companies prepare for these challenges, experts like Hawkins focus on navigating the evolving market and helping businesses succeed in this new environment.
As the <a href="https://www.benzinga.com/events/cannabis-conference/">Benzinga Cannabis Capital Conference </a>approaches, industry leaders and investors will pay close attention to how these developments unfold in California and beyond.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/10/41156918/fed-health-official-cannabis-industry-borrowing-marketing-tactics-from-tobacco-alcohol-industrie">Fed Health Official: Cannabis Industry Borrowing Marketing Tactics From Tobacco, Alcohol Industries</a></li>
</ul>
Image: AI generated image.

Events

California's Hemp Ban 'Likely Won't Be The Last': Will It Push Consumers Back To Licensed Operators?

<ul>
<li>NVDA</li>
<li>BABA</li>
<li>WAY</li>
<li>MADE</li>
<li>AI</li>
<li>TSLA</li>
<li>NIO</li>
<li>RKLB</li>
<li>HIMS</li>
<li>AAPL</li>
</ul>
Data from <a href="https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment">https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment</a>
&nbsp;

Trading Ideas

AAPL

BABA

MADE

NVDA

RKLB

TSLA

Top 10 Trending Stocks On WallStreetBets As Of October 3, 2024 (Via Swaggy Stocks)

First deliveries of Bollinger B4 electric trucks to Nacarato Truck Centers with a value of $800,000
&nbsp;First revenue recognized for three months ended Sept. 30, 2024, with wire transfer payment received on Sept. 30, 2024
BREA, Calif., Oct. 03, 2024 (GLOBE NEWSWIRE) -- via IBN –&nbsp;<a href="https://www.globenewswire.com/Tracker?data=0beGGw51i2VXyAdN3CHnvEBI4lRvoJMFOHx1R5J14OUfY7JQKISYpCOcF7lSngUr0GIr4NZ2y9NzKBFmt3Dzr24rYzw3tzEcjV7pXQE286c=">Mullen Automotive, Inc</a>. (NASDAQ:&nbsp;<a href="https://www.globenewswire.com/Tracker?data=pPH1TVPUboaGiAU4v7mGw-MWsRtOATAHF3ui-WJyIYIZXeqQTXZ5Qlf5U_JG7YwlBEXYeSD3Cn0f_SC-YdqubUzsQF0oDvQesaSS0ayWZbr1asLLnwSx6x0qoWtO5xh3wKOfukq_UYK150JvzLSkPTIIK9KaVrchyCbE0KqTfm8qgW6lojud7nSS5Gs38OlJjjhVSXW7yfrlgoBOXe4SAOP1hWdvHpqIkcF_Q81sbnBavcXil5pqcVE-w9yH0k_t">MULN</a>) ("Mullen" or the "Company"), an electric vehicle ("EV") manufacturer, announces today that its subsidiary, <a href="https://www.globenewswire.com/Tracker?data=hOad4maJjHRBU4avvnII-bKE_rZI03KQB6nG33pLdFBAj3vxQmRq7BabLJ97OpGQdIfWbhe-Jm04hn2G6BqVZ4KDF4dj3P1rGR0aMmLma9s=">Bollinger Motors</a> ("Bollinger"), has made the first customer delivery of its 2025 Bollinger B4 Chassis Cab. Bollinger delivered five Bollinger B4s to Nacarato Truck Centers' LaVergne, Tennessee, facility – generating revenue for the original equipment manufacturer (OEM) with a MSRP value of $800,000. Revenue from the Nacarato delivery is recognized for the three months ended Sept. 30, 2024, with wire transfer payment received on the vehicles delivered.
Nacarato Truck Centers will sell four vehicles to commercial fleet customers and use one vehicle for its own internal parts deliveries between its 13 locations throughout the East, Southeast and Midwest.

MULN

Mullen Announces First Deliveries Of Bollinger B4 Electric Trucks To Nacarato Truck Centers With A Value Of $800,000

Weekly Initial Jobless Claims for the week ending September 28 were 225,000, an increase of 6,000 from the previous week&#8217;s revised level, according to data the Labor Department&nbsp;<a target="_blank" href="https://www.dol.gov/ui/data.pdf" rel="noreferrer noopener">released</a> on Thursday.
The number is above the average economist estimate of 221,000, as per data from <a target="_blank" href="https://www.benzinga.com/pro/feature/newsfeed" rel="noreferrer noopener">Benzinga Pro</a>.
The previous week&#8217;s level was revised higher by 1,000 from 218,000 to 219,000.
Also Read: <a target="_blank" href="https://www.benzinga.com/government/24/09/40831961/european-central-bank-cuts-key-interest-rates-as-inflation-cools" rel="noreferrer noopener">European Central Bank Cuts Key Interest Rates As Inflation Cools</a>.
The 4-week moving average was 224,250, a drop of 750 from the previous week&#8217;s revised average of 225,000.
The advance seasonally adjusted insured unemployment rate was 1.2% for the week ending September 21, unchanged from the previous week&#8217;s revised rate.
The advance number for seasonally adjusted insured unemployment during the week ending September 21 was 1,826,000, a decrease of 1,000 from the previous week&#8217;s revised level.
According to the ADP National Employment Report released on Wednesday, the U.S. private sector added 143,000 jobs in September, surpassing expectations of 124,000 and reflecting a&nbsp;rebound in job creation&nbsp;following a <a target="_blank" href="https://www.benzinga.com/news/econ-s/24/10/41139919/private-sector-job-gains-outpace-forecasts-in-september-as-us-adds-143-000-jobs" rel="noreferrer noopener">five-month slowdown</a>.
The labor market&nbsp;is expected to show a modest increase of 140,000 jobs, slightly down&nbsp;from August&#8217;s 142,000, as nonfarm payroll will release its report on Friday.
The slowdown in job creation and tempered wage growth point to a cooling labor market that may give the Fed room to consider <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41148891/jobs-report-in-focus-will-slower-growth-push-the-fed-toward-november-interest-rate-" rel="noreferrer noopener">additional easing measures</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/asia/24/10/41160573/asia-mixed-europe-markets-fall-while-crude-rises-on-middle-east-tensions-global-markets-today-while" target="_blank" rel="noreferrer noopener">Asia Mixed, Europe Markets Fall While Crude Rises On Middle East Tensions – Global Markets Today While US Slept</a></li>
</ul>
Photo via Shutterstock

Government

Macro Economic Events

Econ #s

Economics

Markets

General

US Weekly Jobless Claims Increase Modestly To 225K

B. Riley Securities analyst Madison El-Saadi maintains WAVE Life Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WVE#NASDAQ">WVE</a>) with a Buy and raises the price target from $11 to $19.

B. Riley Securities Maintains Buy on WAVE Life Sciences, Raises Price Target to $19

Equinox Gold shares are trading lower after the company announced it has issued 24,761,905 shares.

Dogecoin&#8216;s (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>) bearish price action could spell more weakness, as traders <a href="https://www.benzinga.com/money/dogecoin-doge-price-prediction">see looming weakness</a> on the charts.
What Happened: Crypto trader Kevin highlighted Dogecoin&#8217;s weakness on the weekly chart. After a failed breakout from a six-month falling wedge and a strong rejection at the 200-week simple moving average, a bearish engulfing candle is now forming, signalling a potential return to the falling wedge.
If this pattern holds, it could be one of the most bearish setups that Kevin has encountered.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">The weekly time frame on <a href="https://twitter.com/hashtag/Dogecoin?src=hash&amp;ref_src=twsrc%5Etfw">#Dogecoin</a> looks so bad I can't even put it into words. Massive failure breakout of 6 month falling wedge after getting a huge rejection off weekly 200 SMA and now we have a bearish engulfing candle forming on the weekly after entering back into the… <a href="https://t.co/5WCgeO7rX0">pic.twitter.com/5WCgeO7rX0</a>
&mdash; Kevin (@Kev_Capital_TA) <a href="https://twitter.com/Kev_Capital_TA/status/1841573343943917987?ref_src=twsrc%5Etfw">October 2, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Another crypto trader, Altstein Trade, commented on Kevin&#8217;s post, <a href="https://x.com/Altsteinn/status/1841576587952816465">saying</a> that the 200 SMA rejection was brutal and advising to reevaluate positions before the meme coin sinks deeper. He concluded, "Watching closely for any hope of a bounce, but not holding my breath."
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/09/41092021/dogecoin-up-19-shiba-inu-surges-32-in-september-whats-next-for-the-meme-coin-leaders">Dogecoin Up 19%, Shiba Inu Surges 32% In September: What&#8217;s Next For The Meme Coin Leaders?</a>
Why It Matters: IntoTheBlock data shows large transaction volume increased by 10.3% and daily active addresses fell by 33.5%. Transactions greater than $100,000 are down from 439 to 303 in a single day. Exchanges netflows are down by 20.3%.
Coinglass data reports Dogecoin short liquidations at $217,500, the lowest level since Sep. 22.
Price Action: In the past 24 hours, DOGE is trading 1.9% down at $0.1043, bringing its seven-day losses to around 9%. The meme coin leader is up 4.4% over the past 30 days, underperforming its rival Shiba Inu, which has seen a 19% increase.
What&#8217;s Next: The influence of meme coins is expected to be thoroughly explored at Benzinga&#8217;s upcoming <a href="https://www.benzinga.com/events/digital-assets/agenda/" target="_blank" rel="noreferrer noopener">Future of Digital Assets</a> event on Nov. 19.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41126743/dogecoin-down-7-what-is-going-on">Dogecoin Down 7%: What Is Going On?</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$DOGE

Dogecoin Down 2% And Technical Analysis Says It Could Get Much Worse

Elon Musk expressed concerns over the financial trajectory of the United States, suggesting the nation is on the brink of bankruptcy. 
What Happened: As per economist E.J. Antoni on Thursday, Federal debt increased by $204 billion on the very first day of the new fiscal year, jumping to a new record of $35.669 trillion.
Additionally, the Treasury had to reduce its cash reserves by $72 billion, resulting in a deficit exceeding $275 billion in just one day.
Musk responded, &#8220;America is headed for bankruptcy.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">America is headed for bankruptcy <a href="https://t.co/sxse13AOQs">https://t.co/sxse13AOQs</a>
&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1841745397406171274?ref_src=twsrc%5Etfw">October 3, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/markets/equities/24/09/41108682/michael-dell-sells-1-2-billion-worth-of-dell-stock-reducing-stake-amid-companys-recent-s-p-500-r?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Michael Dell Sells $1.2B Worth Of Dell Stock, Reducing Stake Amid Company&#8217;s Recent S&amp;P 500 Inclusion And AI Expansion</a>
Why It Matters: The issue of national debt is not new but has gained increased attention. Former Coinbase Global Inc. CTO, Balaji Srinivasan, argues that the <a href="https://www.benzinga.com/economics/macro-economic-events/24/08/40368118/true-us-debt-is-175-trillion-former-coinbase-cto-on-unpayable-crisis">actual U.S. debt</a> is much higher when considering entitlements like Social Security and Medicare. He estimates the real figure to be $175.3 trillion. This perspective suggests that the financial obligations of the U.S. are far greater than the reported $35 trillion, raising questions about fiscal sustainability.
Earlier, Robert Kiyosaki, the renowned financial educator and the author of the best-selling book Rich Dad, Poor Dad, also expressed his concerns over the escalating U.S. debt.<a href="https://www.benzinga.com/news/24/09/40869188/robert-kiyosaki-rings-alarm-bells-over-soaring-us-debt-the-dollar-is-trash"> In a series of posts on X</a>, Kiyosaki warned about the growing $35 trillion U.S. debt, calling it "the real problem" that "neither [Donald] Trump nor Kamala [Harris] can solve."
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/09/41084992/nvidia-stock-could-touch-800-by-2030-bgg-executive-predicts-550-upside-driven-by-ai-revolution-a?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Nvidia Stock Could Touch $800 By 2030, BGG Executive Predicts 550% Upside Driven By AI Revolution And Web3 Transition</a></li>
</ul>
Image via Shutterstock
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/topic/Pooja-Rajkumari" target="_blank" rel="noreferrer noopener">Pooja Rajkumari</a>

Elon Musk Says America 'Headed For Bankruptcy' As National Debt Skyrockets $204B In A Day

SXTP

60 Degrees Pharmaceuticals shares are trading higher after the company announced commenced a nine-month ARAKODA promotional pilot.

Onconetix, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONCO#NASDAQ">ONCO</a>) ("Onconetix" or "the Company") (formerly Blue Water Biotech, Inc. (BWV)), a cancer diagnostics company focused on the research, development and commercialization of innovative solutions for oncology, today announced the signing and closing of a private placement of (i) 3,499 shares of the Company's Series C Convertible Preferred Stock, $0.00001 par value (the "Series C Preferred Stock"), and (ii) warrants (the "Warrants") to acquire up to an aggregate of 591,856 additional shares of the Company's common stock, $0.00001 par value per share (the "Common Stock"), for&nbsp;aggregate gross proceeds of approximately $2.0&nbsp;million. The Series C Preferred Stock are initially convertible into an aggregate of 776,590 shares of Common Stock, subject to certain anti-dilution adjustments. The Warrants will have an exercise price of $4.38 per share, subject to customary adjustments, and are exercisable beginning six months and one day after the issuance date (the "Initial Exercisability Date") and expiring on the third anniversary of the Initial Exercisability Date. The Company has filed a Current Report on Form 8-K with the Securities and Exchange Commission on October 3, 2024, with additional details of the transaction. The Company agreed to seek stockholder approval for the issuance of all of the shares of Common Stock issuable upon conversion of the Series C Preferred Stock and exercise of the Warrants in accordance with the rules and regulations of the Nasdaq Stock Market. The Company intends to use the gross proceeds from the private placement for working capital and general corporate purposes. Tungsten Advisors (through its broker-dealer, Finalis Securities, LLC), served as financial advisor to Onconetix.

Offerings

ONCO

Onconetix Announces Financing Through A $2M Private Placement Of Series C Preferred Stock And Warrants; Establishes A $25 Million Equity Line Of Credit

Company to Kick-Off Hiring on October 8 with Annual National Signing Day

Dick's Sporting Goods Plans To Hire Nearly 8,000 Seasonal Employees For Holiday Season

<ul>
<li>Highlights include increased ARAKODA&#xAE; (tafenoquine) brand awareness and utilization through virtual sales outreach using digital behavioral analytics and a co-pay program to assist consumers with out-of-pocket costs. &nbsp;</li>
<li>ARAKODA is the only new antimalarial in over a decade and is differentiated by a broad efficacy against all malaria stages, a convenient weekly dosing schedule, and a well-established safety profile. &nbsp;</li>
</ul>
WASHINGTON, Oct. 03, 2024 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=ZyGvehXAdBpGA8TrpWB-xSukUbIYIRRq7w5PFZBxGra-WsKLNrSqLryRFHOZhjN18z9I6bCNe922xp6iSICkSjV7Z4YqQkscwxLvGpLQQbBuJvL8ef2nTNFfMxzHF96zcek-8TGluoBgseTskv3npt9A7NLeLtDpFtYpin_iU1qFU-cOrLa4M2q8iNAGcTcS-cOBzxjVCxb0Ecry6lsl_M_LCftKKYCopD2MAz_K64JzjOGvyjtiic1AEbGWfVy9nmbcawYUW5t6dDFUq_yqXPJNHWDOuHrGiKGsyTRfrP0pT8u1dSVddavypJyH7tPI4r76ntRoGauLI9KjF6uugz-P3EH0UBI4Z6yLRXnEjMxNGVqA8-9MdHu7xw3Ir0LtMvboBBMc5ttPWPExXobANlFop_KMqRqLApvpwC2GIao=">60 Degrees Pharmaceuticals, Inc.</a>&nbsp;(NASDAQ:&nbsp;<a href="https://www.globenewswire.com/Tracker?data=0jA46dn5vhQQwLyIftlITzsmY1bU0GQuMNaCDf1DO5ysY1peetAI0dkUBeQq2JUW3FaQz6muvFMMVWowR8bIyMMCd8jP9fv1s-fykdjiAfpaj38EGJ5qj8ag51_djBa9vLBq7H6zP8Z1U4Y2fnknt_aNJjRLJP3GL5FVHlNDSwqkTz4oNaexlJX0XDSY1kgjMMx7iTwAsZNEvhsOLFni54JOktf0tMpfBTelqJHkjtvIgd6piXTNWBWW1IGvgMifpxdiQGVCHMEzMV6LEDj4bsG2ZpVPpZp93IYXyog0Wosifi_wwniRCkAQFMZVRFGKQVkfTnc642EfpyepxRmVmUQ82SWKkWvW0QPKOo5WApzNYTM7Yco9xyLMTSgw468EQLr6FMKBD0q586lRmGvS9Q==">SXTP</a>; SXTPW) (the "Company"), a pharmaceutical company focused on developing new medicines for infectious diseases, announced today that the Company has commenced a nine-month promotional pilot to bring greater awareness of ARAKODA&#xAE; (tafenoquine) and its benefits to patients and healthcare providers who prescribe it.
ARAKODA (tafenoquine) is an antimalarial&nbsp;indicated for the prevention of malaria&nbsp;in patients aged 18 years and older.

Biotech

60 Degrees Pharmaceuticals Announces ARAKODA Promotional Pilot In Advance Of Expanded U.S. Launch Indicated For The Prevention Of Malaria In Patients Aged 18 Years And Older

<a href="https://www.globenewswire.com/Tracker?data=i40ygf2ui6i7jaCnv6Tn8q3l9CaBR1hM60bR-7QTQpmEQAjugQ-Mj1BKq-SIAakHnN5fkjUx3eH5a0Q0iYw_SBtsaEAJoKxOEeTaZiM-yuE=">Zoom Video Communications, Inc.</a> (NASDAQ:<a href="https://www.benzinga.com/stock/ZM#NASDAQ">ZM</a>) today announced the launch of its industry-leading Zoom Phone in India, commencing with the availability of Zoom Phone service with native India phone numbers in the Maharashtra Telecom Circle (Pune). Zoom Phone brings multinational corporations (MNCs) with a domestic presence and homegrown companies unrivaled simplicity and modern functionality to their distributed hybrid workforce, as well as global native coverage in 50 countries and territories. &nbsp;
The native phone number support will be available starting with the Maharashtra Telecom Circle (Pune), followed by Karnataka (Bangalore), Tamil Nadu (Chennai), Andhra Pradesh (Hyderabad), Mumbai and Delhi telecom circles, covering all the major technology centers in India.
Zoom India received <a href="https://www.globenewswire.com/Tracker?data=7EEoCm9iY5IvxhzsmgbEwT0eRpB3VVGKkpeRgZ2ZN68n83Yp7wAEXvSXgSgIu8l8GCcj8B41SUQ9oyzHDvqCsGQqmTZbk6xDPeOAWK_m7W6kV4_AuMFHqGBgwpsN6i5a0RqOuVpe3kyGr7chYj0O79GUYiMRlahcGQjTqAMl7pp2qz0Xw15F9MjVwqtloBcNk_i78if8rjK2AruR_6jLIVgPaL7MuU5aVgKONQ-ZKT0=">the Unified License with Access — All/PAN India and Long Distance </a>licenses from the Department of Telecommunications (DoT), Government of India, in April 2023. Thereafter, Zoom India focused on establishing its dedicated domestic infrastructure for Zoom Phone in India and complying with regulatory requirements. This effort enables Zoom to lead the industry with the launch of the first-of-its-kind licensed cloud private branch exchange (PBX) service bundled with local phone numbers for India.

Global

Zoom Phone Now Available in India; Zoom Phone Brings Multinational Corporations With A Domestic Presence And Homegrown Companies Unrivaled Simplicity And Modern Functionality To Their Distributed Hybrid Workforce, As Well As Global Native Coverage In 50 Countries And Territories

HUMBLE deepens financial tie-up with Pacific Lion, introduces Series C preferred shares

HUMBL announces exchange of debt for preferred stock

Press Releases

HUMBL ANNOUNCES LAUNCH OF NEW AFL LEAGUE WEBSITE

Humbl Announces Launch of New Afl Mobile Application

HUMBL Announces Launch of Seamless Identity Verification with Dojah

HUMBL Announces Launch of Government Digital Wallet with the County of Santa Cruz

HUMBL Launches New HUMBL.com Platform and Verification Features

HUMBL and the Arena Football League (AFL) Launch Innovative Digital Ticketing Program on Blockchain

HUMBL Announces Purchase of HUMBL Financial by Avrio, to Drive a Range of Financial Products and Services into the Global Markets

Minnesota Myth of the AFL Signs Merchandising Deal with HUMBL Authentics

HUMBL Reduces Stockholders' Deficit by over $33 Million Since the End of Calendar Year 2022

HUMBL and the Oregon BlackBears Deliver Innovative Digital Ticketing Program

HUMBL

In 2023, top executives in the cannabis industry continued to play a pivotal role in shaping the future of the rapidly growing market.



These executives championed sustainability, social responsibility and inclusive business practices on the path to creating a more diverse and equitable cannabis industry. Their leadership contributed to the normalization of cannabis, driving mainstream acceptance and reshaping public perceptions.



Humble &amp; Fume Inc. (CSE:<a class="ticker" href="https://www.benzinga.com/stock/HMBL#CSE">HMBL</a>) (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/HUMBF#OTCQX">HUMBF</a>), kicked off 2023 by <a href="https://www.benzinga.com/markets/cannabis/23/01/30406998/key-marijuana-executive-changes-you-should-know-about-this-company-got-a-new-ceo-more-news">naming Jakob Ripshtein</a> as its new CEO. He replaced Joel Toguri. Under Ripshtein's guidance, the company reported <a href="https://www.benzinga.com/markets/cannabis/23/10/35463550/canadas-top-weed-accessory-distributor-will-ramp-up-in-california-reports-2023-sales-uptick">positive financial results</a> for the full year of 2023. The company plans to intensify its efforts in the California cannabis sector going forward.



In February, cannabis social media platform WeedTube <a href="https://www.benzinga.com/markets/cannabis/23/02/31022325/keeping-up-with-cannabis-key-industry-and-executive-changes-you-should-know-about">elected Maggie Adair</a> as its new CEO. Adair, a graduate of George Washington University with degrees in Communications and Political Management, has had a successful career in the political realm of Washington D.C., working for top political officials in media, campaigns, <a href="https://www.benzinga.com/markets/cannabis/23/02/30989888/meet-the-new-ceo-of-weedtube-a-political-powerhouse-with-a-passion-for-cannabis">and the tech field.</a>



Cannabis multi-state operator MariMed.'s (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/MRMD#OTCQX">MRMD</a>) (CSE:<a class="ticker" href="https://www.benzinga.com/stock/MRMD#CSE">MRMD</a>) board of directors tapped Edward Gildea to serve as their chairman and <a href="https://www.benzinga.com/markets/cannabis/23/03/31195566/latest-executive-changes-in-marijuana-industry-new-appointments-more">Jon Levine as CEO in March.</a> Levine, the company&#8217;s co-founder and president, who was one of the speakers at April&#8217;s Cannabis Capital Conference. Levin took over as interim CEO after the untimely death of co-founder, chairman and CEO Bob Fireman. The company, one of analyst's favorite stocks closed a $58.7 million secured credit facility with a U.S. chartered bank in November and is now <a href="https://www.benzinga.com/markets/cannabis/23/11/35874567/one-of-analysts-favorite-marijuana-stocks-says-farewell-to-debt-closes-58-7m-refinancing-deal">expected to "generate significant cash savings."</a>



July was a busy month in the cannabis sector with <a href="https://www.benzinga.com/markets/cannabis/23/07/33280078/top-talent-to-lead-two-new-us-marijuana-markets-and-latest-key-hires-in-cannabis-industry">several companies naming new CEOs:</a>



<ul>
<li>Sabas Carrillo agreed to lead the California-based cannabis producer Unrivaled Brands, Inc (OTCQB:<a class="ticker" href="https://www.benzinga.com/stock/UNRV#OTCQB">UNRV</a>);</li>



<li>iAnthus Capital Holdings, Inc. (CSE:<a class="ticker" href="https://www.benzinga.com/stock/IAN#CSE">IAN</a>) (OTCPK: ITHUF) appointed Richard Proud as CEO and the board&#8217;s director;</li>



<li>PharmaCielo Ltd. (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/PCLOF#OTCQX">PCLOF</a>) (TSXV:<a class="ticker" href="https://www.benzinga.com/stock/PCLO#TSXV">PCLO</a>) the Canadian parent of Colombia&#8217;s premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S. named Marc Lustig as chairman and CEO;</li>



<li>MedMen Enterprises Inc. (CSE:<a class="ticker" href="https://www.benzinga.com/stock/MMEN#CSE">MMEN</a>) (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/MMNFF#OTCQX">MMNFF</a>) appointed Ellen Deutsch as CEO; and</li>



<li>Flora Growth Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLGC#NASDAQ">FLGC</a>) tapped <a href="https://www.benzinga.com/markets/cannabis/23/07/33119512/leadership-shake-ups-across-several-weed-companies-who-got-the-top-jobs">Clifford Starke to serve as CEO.</a></li>
</ul>



In September, Charlotte&#8217;s Web (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/CWBHF#OTCQX">CWBHF</a>) (TSX: CWEB) tapped William Morachnick as CEO, succeeding CEO Jacques Tortoroli, who resigned from <a href="https://www.benzinga.com/markets/cannabis/23/09/34534219/former-reynolds-american-executive-joins-charlottes-web-as-new-ceo">his roles at the Colorado-based company.</a>



Cannabis veteran executive Gary Santo agreed to assume the CEO role at RX Green Technologies in October, <a href="https://www.benzinga.com/markets/cannabis/23/10/35289402/marijuana-veteran-gary-santo-to-lead-denver-maker-of-cannabis-cultivation-inputs-and-services">replacing Wes Matelich</a>. Cannabis-focused commercial real estate finance company AFC Gamma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFCG#NASDAQ">AFCG</a>) wrapped up the month by tapping industry veteran <a href="https://www.benzinga.com/markets/cannabis/23/10/35491822/cannabis-lender-taps-industry-veteran-as-ceo-to-gain-in-house-operating-expertise">Daniel Neville as its new CEO.</a>



In November, the governmental cannabis retail monopoly in the Canadian province of Quebec, the Société québécoise du cannabis (SQDC) named<a href="https://www.benzinga.com/markets/cannabis/23/11/35560804/woman-takes-helm-of-quebecs-cannabis-retail-monopoly-and-more-industry-changes"> Suzanne Bergeron</a> as its new president and CEO. Cannabis vape producer The Blinc Group promoted Pete Sahani, the company's COO since 2022, to <a href="https://www.benzinga.com/markets/cannabis/23/11/36003747/cannabis-industrys-new-mavericks-two-companies-introduce-fresh-leadership">CEO a month ago.</a>



This week, Kaival Brands Innovations Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KAVL#NASDAQ">KAVL</a>) announced that it has expanded the role of Barry M. Hopkins, executive chairman, to include the positions of interim CEO and president.



Missed the first wave of cannabis investments? Don't make that mistake again. Experts believe <a target="_blank" href="https://marketfy.com/item/420investor/" rel="noreferrer noopener">cannabis stocks have found their floor</a> and are now poised for unprecedented growth. Join <a target="_blank" href="https://marketfy.com/item/420investor/" rel="noreferrer noopener">Benzinga PotProfits</a>. Our in-house canna stock expert, Michael Berger, is on a mission to uncover the most promising <a target="_blank" href="https://marketfy.com/item/420investor/#overview-page" rel="noreferrer noopener">cannabis stocks poised for growth</a>, even in a dull market. He leaves no bud unturned to bring you the juiciest potential double-digit opportunities! &nbsp;Just this year, the PotProfits <a target="_blank" href="https://marketfy.com/item/420investor/#overview-page" rel="noreferrer noopener">portfolio</a> has seen smoking-hot gains like:



<ul>
<li>&nbsp;47.10% with $GTBIF</li>



<li>&nbsp;40.23% with $TCNNF</li>



<li>&nbsp;21.50% with $VFF</li>
</ul>



&nbsp;But here's the kicker: Michael is about to release his <a target="_blank" href="https://marketfy.com/item/420investor/#overview-page" rel="noreferrer noopener">next potential winners</a>, and he's chomping at the bit to share these ticker symbols with you ASAP.



Don't miss out on the <a target="_blank" href="https://marketfy.com/item/420investor/#overview-page" rel="noreferrer noopener">green rush</a>!

HUMBL (OTC:<a class="ticker" href="https://www.benzinga.com/stock/HMBL#OTC">HMBL</a>) has outperformed the market over the past 5 years by 234.07% on an annualized basis producing an average annual return of 243.22%. Currently, HUMBL has a market capitalization of $39.29 million. 
Buying $100 In HMBL: If an investor had bought $100 of HMBL stock 5 years ago, it would be worth $4,762.50 today based on a price of $0.02 for HMBL at the time of writing.
<h3>HUMBL's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2023/1675884911_0.png" alt="comp_fig" />

Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

Dividends

Here's How Much $100 Invested In HUMBL 5 Years Ago Would Be Worth Today

Top Stock Ideas Sent Daily — Join and Gain Your Edge

Top Stock Ideas Sent Daily — Join and Gain Your Edge

Comments

HUMBL

News

Latest news for HUMBL (OTC:HMBL) Stock

Friday, December 29, 2023

Wednesday, February 08, 2023